Q0247 Injection, sotrovimab, 500 mg

Short descriptor: Sotrovimab

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q0247 was terminated as of 2024-12-12 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q0247 in the app →

Look up Q0247 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q0247 is the HCPCS Level II code for Injection, sotrovimab, 500 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Vaccinations.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Vaccinations (indicator 54)
Type of Service
Pneumococcal/flu/hepatitis B vaccine
Effective Date
2024-12-13
Termination Date
2024-12-12
2026 Maintenance
No change this year

References

Cite This Page

Reference Q0247 with the canonical source and edition:

Q0247 — Injection, sotrovimab, 500 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q0247

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q0247

Related Codes in Section Q

← Q0245 Bamlanivimab and etesevima Q0249 → Tocilizumab for covid-19
Q0240 Casirivi and imdevi 600 mg Q0243 Casirivimab and imdevimab Q0244 Casirivi and imdevi 1200 mg Q0245 Bamlanivimab and etesevima Q0249 Tocilizumab for covid-19 Q0477 Pwr module pt cable lvad rpl Q0478 Power adapter, combo vad Q0479 Power module combo vad, rep Q0480 Driver pneumatic vad, rep Q0481 Microprcsr cu elec vad, rep
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial